Altered lipidomic profiles in patients with and without osteonecrosis of the femoral head after 1‐month glucocorticoid treatment

The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis

(2020) Christopher Chang et al.   JOURNAL OF AUTOIMMUNITY

Trans‐omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancer

(2020) Zhenhua Zhu et al.   Clinical and Translational Medicine

Serum Biomarkers Related to Glucocorticoid‐Induced Osteonecrosis of the Femoral Head: A Prospective Nested Case‐Control Study

(2019) Xin‐Yuan Wang et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Chronic dexamethasone exposure markedly decreased the hepatic triglyceride accumulation in growing goats

(2018) Qu Chen et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Metabolomic study of the bone trabecula of osteonecrosis femoral head patients based on UPLC–MS/MS

(2016) Weiwen Zhu et al.   Metabolomics

High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus

(2015) Takeshi Kuroda et al.   CLINICAL RHEUMATOLOGY

Unique plasma metabolomic signature of osteonecrosis of the femoral head

(2015) Xiaolin Liu et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway

(2009) S. Okazaki et al.   RHEUMATOLOGY